• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT; HEART-VALVE, MECHANICAL Back to Search Results
Model Number 27VAVGJ-515
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Atrial Fibrillation (1729); Hemorrhage/Bleeding (1888)
Event Date 04/28/2022
Event Type  Injury  
Manufacturer Narrative
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
Clinical information: (b)(6), patient site id: (b)(6).It was reported that on (b)(6) 2022, a 27mm sjm masters series valsalva aortic valved graft was implanted.There were no adverse intraprocedural events reported.On (b)(6) 2022, the patient developed post-operative bleeding due to the operation.The patient was returned to surgery, and it was noted that the bleeding was coming from the graft anastomosis.The bleeding was stopped.The patient's hemoglobin was 4.6 mmol/l, and the patient received 3 units of red blood cells (rbc), 2 units of platelets, and 3 units of plasma.On (b)(6) 2022, the patient developed atrial fibrillation, which was treated with amiodarone.The atrial fibrillation resolved on (b)(6) 2022.On (b)(6) 2022, hemoglobin was 5.0 mmol/l, and the patient received one unit of rbc.On (b)(6) 2022, the patient was re-admitted to the hospital due to hypervolemia, which was treated with diuretics and was resolved by (b)(6) 2022.
 
Manufacturer Narrative
An event of bleeding after the implant procedure was reported.It was also reported that three days after the implant procedure the device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications information from the field indicated the bleeding was due to the operation and that the bleeding was coming from the graft anastomosis.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MASTERS SERIES HEART VALSALVA AORTIC VALVES GRAFT
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL PUERTO RICO, INC. REG#2648612
20 b st caguas west park
caguas 00725
*   00725
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key14595122
MDR Text Key293290194
Report Number2135147-2022-00337
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier05414734009515
UDI-Public05414734009515
Combination Product (y/n)N
Reporter Country CodeDA
PMA/PMN Number
P810002
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/10/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/03/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/31/2022
Device Model Number27VAVGJ-515
Device Catalogue Number27VAVGJ-515
Device Lot Number7431010
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/02/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/08/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age38 YR
Patient SexFemale
Patient Weight78 KG
Patient RaceWhite
-
-